Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

Journal of Neural Transmission

Volumn 89, Issue 1-2, 1992, Pages 1-10

  Hoffman, D C ^a  

^a NEUROGEN CORPORATION   (United States)

Author keywords

Clozapine; D 2 receptors; dopamine; eticlopride; glutamate; haloperidol; locomotion; MK 801; NMDA receptors; schizophrenia; stereotypy

Indexed keywords

CLOZAPINE; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; GLUTAMIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SNIFFING; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SALICYLAMIDES; STEREOTYPED BEHAVIOR;

EID: 0026779303     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/BF01245347     Document Type: Article

References (38)

1. Phencyclidine-induced psychosis
2. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
3. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen
4. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions
5. Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine
6. Climbing behavior induced by apomorphine in mice: a potential model for the detection of neuroleptic activity
7. Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3 H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides
8. Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia
9. A “glutamatergic hypothesis” of schizophrenia. Rationale for pharmacotherapy with glycine
10. Animal models with construct validity for schizophrenia
11. Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists
12. The topography of MK-801-induced locomotor patterns in rats
13. Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A 10 dopamine neurons
14. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia
15. The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits
16. New selective dopamine D 2 antagonists as antipsychotic agents
17. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus
18. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes
19. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
20. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
21. Presynaptic dopaminergic modulation of cortical input to the striatum
22. The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function
23. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action
24. Release-regulating D 2 dopamine receptors are located on striatal glutamatergic nerve terminals
25. Animal models of schizophrenic disorders
26. The Phencyclidine receptor complex: Interaction with excitatory amino acids and endogenous ligands
27. Remoxipride a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain
28. The selective dopamine D 2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions
29. Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats
30. Hyperactivity induced by N-methyl-D-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons
31. In vivo demonstration of the enhancement of MK-801 by L-glutamate
32. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy
33. Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine
34. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats
35. Brain dopamine receptors
36. Dopamine receptors and dopamine hypothesis of schizophrenia
37. MK-801-induced stereotypy and its antagonism by neuroleptic drugs
38. Regulation of [3H] dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors